Severe Late-Onset Neutropenia in a Pregnant Patient with Multiple Sclerosis after Ocrelizumab
Neurologists should be aware of this risk and consider additional hematologic monitoring for pregnant patients who received anti-CD20 therapy as therapies such as G-CSF are available to help prevent serious infections.
Authors
- Scott D. Gitlin
- Marisa J.L. Aitken (ORCID: https://orcid.org/0000-0002-7937-531X)
- Casey Fealko (ORCID: https://orcid.org/0000-0002-4092-6858)
- Morgan N Rolon-Newton
Institutions
- University of Michigan (US)
Publication Details
- Journal
- Case Reports in Neurology
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1159/000544749
- Citations
- 1
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.82